category,subcategory,ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
Organismal Systems,Immune system,hsa04657,IL-17 signaling pathway,10/103,95/8538,0.10526315789473684,8.725600408788962,8.367088430170133,1.8099718977316113e-7,4.000037893986861e-5,3.429420437807263e-5,MMP1/CXCL8/IL6/CXCL1/MMP13/MAPK13/CCL20/MMP3/S100A8/PTGS2,10
Human Diseases,Immune disease,hsa05323,Rheumatoid arthritis,9/103,95/8538,0.09473684210526316,7.853040367910067,7.422076180460595,1.8911685770638214e-6,2.0897412776555227e-4,1.7916333887973046e-4,MMP1/CXCL8/IL6/CXCL1/CCL20/MMP3/ATP6V0D2/HLA-DRB1/HLA-DRB5,9
Human Diseases,Infectious disease: parasitic,hsa05146,Amoebiasis,8/103,103/8538,0.07766990291262135,6.438307097747194,6.135762018991524,3.1509533876485595e-5,0.0023212023289011056,0.001990075823778037,COL3A1/CXCL8/IL6/CXCL1/LAMC2/COL4A6/SERPINB3/COL4A3,8
Human Diseases,Endocrine and metabolic disease,hsa04933,AGE-RAGE signaling pathway in diabetic complications,7/103,101/8538,0.06930693069306931,5.745073536479862,5.3007621711008195,2.0594277657417638e-4,0.010309992581702492,0.008839241079811615,COL3A1/CXCL8/IL6/MAPK13/COL4A6/NOX4/COL4A3,7
Environmental Information Processing,Signaling molecules and interaction,hsa04060,Cytokine-cytokine receptor interaction,12/103,298/8538,0.040268456375838924,3.337981364436046,4.539565439136872,2.3325775071725096e-4,0.010309992581702492,0.008839241079811615,IL24/GDF15/CXCL8/IL6/CXCL1/ACKR3/CCL20/IL36B/INHBE/GDF6/TNFRSF8/BMP6,12
Organismal Systems,Nervous system,hsa04726,Serotonergic synapse,7/103,115/8538,0.06086956521739131,5.045673279864922,4.82653029574396,4.5720538044758156e-4,0.016840398179819256,0.0144380646457131,MAOA/HTR3A/MAOB/PTGS2/PLA2G4B/KCNJ6/HTR1D,7
Environmental Information Processing,Signal transduction,hsa04668,TNF signaling pathway,7/103,119/8538,0.058823529411764705,4.876070816676185,4.7050434527455725,5.620481178075974e-4,0.017744662005068433,0.015213332512085344,IL6/BIRC3/CXCL1/MAPK13/CCL20/MMP3/PTGS2,7
Metabolism,Lipid metabolism,hsa00590,Arachidonic acid metabolism,5/103,63/8538,0.07936507936507936,6.578825705039297,4.911022503554051,9.355685768916424e-4,0.025845081936631622,0.02215820313690732,PTGES/PTGS2/PLA2G4B/CYP4F3/ALOXE3,5
Environmental Information Processing,Signaling molecules and interaction,hsa04061,Viral protein interaction with cytokine and cytokine receptor,6/103,100/8538,0.06,4.973592233009708,4.41664249952143,0.0012704810123622358,0.031197367081339345,0.026746968681310223,IL24/CXCL8/IL6/CXCL1/ACKR3/CCL20,6
Human Diseases,Infectious disease: bacterial,hsa05152,Tuberculosis,8/103,182/8538,0.04395604395604396,3.6436573135602264,3.9835506783658614,0.0015489265840237059,0.0342312775069239,0.02934808264465969,IL6/IRAK2/MAPK13/ATP6V0D2/LSP1/HLA-DRB1/CLEC7A/HLA-DRB5,8
Organismal Systems,Immune system,hsa04621,NOD-like receptor signaling pathway,8/103,189/8538,0.042328042328042326,3.508707042687625,3.8538280212374976,0.0019664956358156293,0.03749903363159676,0.0321496835136338,CXCL8/IL6/BIRC3/CXCL1/MAPK13/GBP5/AIM2/MAP1LC3C,8
Human Diseases,Immune disease,hsa05332,Graft-versus-host disease,4/103,45/8538,0.08888888888888889,7.368284789644013,4.732895126093201,0.0020361466225301407,0.03749903363159676,0.0321496835136338,IL6/HLA-DRB1/KLRD1/HLA-DRB5,4
Organismal Systems,Endocrine system,hsa04926,Relaxin signaling pathway,6/103,130/8538,0.046153846153846156,3.8258401792382375,3.587580296161224,0.0047576032399224534,0.08087925507868171,0.0693415856830803,MMP1/COL3A1/MMP13/MAPK13/COL4A6/COL4A3,6
Human Diseases,Cancer: specific types,hsa05222,Small cell lung cancer,5/103,93/8538,0.053763440860215055,4.45662386470404,3.7035864024500063,0.005205872912224966,0.08217842240012269,0.07045542287221758,BIRC3/LAMC2/COL4A6/PTGS2/COL4A3,5
Environmental Information Processing,Signal transduction,hsa04370,VEGF signaling pathway,4/103,60/8538,0.06666666666666667,5.5262135922330105,3.8876993605876056,0.005806559006267363,0.0855499693590058,0.07334600850021931,MAPK13/SH2D2A/PTGS2/PLA2G4B,4
Organismal Systems,Immune system,hsa04640,Hematopoietic cell lineage,5/103,100/8538,0.05,4.144660194174757,3.4952856372043377,0.007059465094153615,0.09090042738902424,0.07793320757334778,CD24/CD22/IL6/HLA-DRB1/HLA-DRB5,5
Human Diseases,Infectious disease: bacterial,hsa05150,Staphylococcus aureus infection,5/103,102/8538,0.049019607843137254,4.063392347230154,3.4392451462913205,0.007664165457016889,0.09090042738902424,0.07793320757334778,KRT17/C4A/KRT15/HLA-DRB1/HLA-DRB5,5
Human Diseases,Endocrine and metabolic disease,hsa04936,Alcoholic liver disease,6/103,144/8538,0.041666666666666664,3.453883495145631,3.281552923508685,0.007770158545845459,0.09090042738902424,0.07793320757334778,CXCL8/IL6/CXCL1/C4A/MAPK13/NOX4,6
Human Diseases,Immune disease,hsa05321,Inflammatory bowel disease,4/103,66/8538,0.06060606060606061,5.0238305383936455,3.6261635339499425,0.008123694405481347,0.09090042738902424,0.07793320757334778,IL6/HLA-DRB1/STAT4/HLA-DRB5,4
Organismal Systems,Immune system,hsa04625,C-type lectin receptor signaling pathway,5/103,105/8538,0.047619047619047616,3.9472954230235784,3.357808921266005,0.00863759717271271,0.09090042738902424,0.07793320757334778,IL6/MAPK13/PTGS2/LSP1/CLEC7A,5
Organismal Systems,Digestive system,hsa04974,Protein digestion and absorption,5/103,105/8538,0.047619047619047616,3.9472954230235784,3.357808921266005,0.00863759717271271,0.09090042738902424,0.07793320757334778,COL3A1/COL17A1/COL4A6/COL4A3/PRSS3,5
Human Diseases,Infectious disease: viral,hsa05167,Kaposi sarcoma-associated herpesvirus infection,7/103,196/8538,0.03571428571428571,2.9604715672676836,3.0681896503250528,0.009353643213233566,0.09396159773293718,0.08055769274555225,CXCL8/IL6/CXCL1/MAPK13/PTGS2/MAP1LC3C/ANGPT2,7
Human Diseases,Infectious disease: bacterial,hsa05120,Epithelial cell signaling in Helicobacter pylori infection,4/103,71/8538,0.056338028169014086,4.670039655408177,3.4313408533262457,0.010463225955922965,0.10053795375039022,0.08619591176504045,CXCL8/CXCL1/MAPK13/ATP6V0D2,4
Human Diseases,Infectious disease: parasitic,hsa05145,Toxoplasmosis,5/103,112/8538,0.044642857142857144,3.7005894590846045,3.1789636481557855,0.011235717903029983,0.1034622356904011,0.0887030360765525,BIRC3/LAMC2/MAPK13/HLA-DRB1/HLA-DRB5,5
Metabolism,Amino acid metabolism,hsa00260,"Glycine, serine and threonine metabolism",3/103,41/8538,0.07317073170731707,6.065356381719157,3.5925087544917873,0.013041662083453105,0.11528829281772544,0.09884207052722353,MAOA/MAOB/GLDC,3
Metabolism,Amino acid metabolism,hsa00380,Tryptophan metabolism,3/103,42/8538,0.07142857142857142,5.920943134535367,3.532599876133184,0.01392390731236994,0.1179633461928128,0.10113551947942988,KYNU/MAOA/MAOB,3
Human Diseases,Infectious disease: bacterial,hsa05133,Pertussis,4/103,78/8538,0.05128205128205128,4.25093353248693,3.1871236981583775,0.014411811525818758,0.1179633461928128,0.10113551947942988,CXCL8/IL6/C4A/MAPK13,4
Human Diseases,Infectious disease: parasitic,hsa05140,Leishmaniasis,4/103,79/8538,0.05063291139240506,4.197124247265577,3.154585167635485,0.015042991879872994,0.11805587047607985,0.1012148448949482,MAPK13/PTGS2/HLA-DRB1/HLA-DRB5,4
Metabolism,Amino acid metabolism,hsa00360,Phenylalanine metabolism,2/103,16/8538,0.125,10.361650485436893,4.141621045482236,0.015491494315865682,0.11805587047607985,0.1012148448949482,MAOA/MAOB,2
NA,NA,hsa04820,Cytoskeleton in muscle cells,7/103,232/8538,0.03017241379310345,2.5010880482089055,2.561432441587151,0.021842525601282307,0.15817245101041388,0.1356086743599643,COL3A1/BGN/LMOD1/SYNE3/COL4A6/COL4A3/LDB3,7
Organismal Systems,Immune system,hsa04672,Intestinal immune network for IgA production,3/103,50/8538,0.06,4.973592233009708,3.1138258838332127,0.0221870858883386,0.15817245101041388,0.1356086743599643,IL6/HLA-DRB1/HLA-DRB5,3
Organismal Systems,Endocrine system,hsa04913,Ovarian steroidogenesis,3/103,52/8538,0.057692307692307696,4.782300224047797,3.0229771618589814,0.024590326456241908,0.165430072792323,0.14183097453021262,PTGS2/PLA2G4B/BMP6,3
Human Diseases,Infectious disease: viral,hsa05171,Coronavirus disease - COVID-19,7/103,238/8538,0.029411764705882353,2.4380354083380924,2.4862667479478926,0.02470222806401203,0.165430072792323,0.14183097453021262,F13A1/MMP1/CXCL8/IL6/C4A/MAPK13/MMP3,7
Organismal Systems,Immune system,hsa04658,Th1 and Th2 cell differentiation,4/103,93/8538,0.043010752688172046,3.565299091763232,2.748579887874241,0.02574657990232925,0.16735276936514012,0.14347939264455928,MAPK13/HLA-DRB1/STAT4/HLA-DRB5,4
Metabolism,Amino acid metabolism,hsa00340,Histidine metabolism,2/103,22/8538,0.09090909090909091,7.535745807590469,3.391699572151385,0.02845790164039137,0.1796913217864712,0.15405781339159236,MAOA/MAOB,2
Human Diseases,Infectious disease: bacterial,hsa05134,Legionellosis,3/103,56/8538,0.05357142857142857,4.440707350901525,2.8544426667086222,0.029802117297489373,0.18295188674292087,0.1568532489341546,CXCL8/IL6/CXCL1,3
Environmental Information Processing,Signal transduction,hsa04064,NF-kappa B signaling pathway,4/103,105/8538,0.0380952380952381,3.157836338418863,2.45839017397913,0.03782699693251408,0.22593963032663816,0.19370866138983028,CXCL8/BIRC3/CXCL1/PTGS2,4
Environmental Information Processing,Signal transduction,hsa04390,Hippo signaling pathway,5/103,157/8538,0.03184713375796178,2.639910951703667,2.2916636794590612,0.04100697002401677,0.2384879046133607,0.204466886546344,BIRC3/AREG/GDF6/BMP6/WNT6,5
Organismal Systems,Immune system,hsa04659,Th17 cell differentiation,4/103,109/8538,0.03669724770642202,3.0419524360915653,2.3708253012654454,0.04246768403274442,0.24023289013885185,0.20596294462964196,IL6/MAPK13/HLA-DRB1/HLA-DRB5,4
Metabolism,Lipid metabolism,hsa00561,Glycerolipid metabolism,3/103,65/8538,0.046153846153846156,3.8258401792382375,2.527053175041906,0.04348106608847997,0.24023289013885185,0.20596294462964196,GPAT3/DGKG/PNLIPRP3,3
Human Diseases,Cardiovascular disease,hsa05417,Lipid and atherosclerosis,6/103,216/8538,0.027777777777777776,2.302588996763754,2.1426396369992204,0.04614605601420607,0.24873849705218395,0.21325520109260826,MMP1/CXCL8/IL6/CXCL1/MAPK13/MMP3,6
Human Diseases,Immune disease,hsa05310,Asthma,2/103,32/8538,0.0625,5.180825242718447,2.6182012394494607,0.05655423088324383,0.29050361351012655,0.2490623978653145,HLA-DRB1/HLA-DRB5,2
Human Diseases,Infectious disease: viral,hsa05164,Influenza A,5/103,173/8538,0.028901734104046242,2.39575733767327,2.0494093260901485,0.057793160781741265,0.29050361351012655,0.2490623978653145,CXCL8/IL6/PRSS3/HLA-DRB1/HLA-DRB5,5
Metabolism,Xenobiotics biodegradation and metabolism,hsa00982,Drug metabolism - cytochrome P450,3/103,73/8538,0.0410958904109589,3.4065700226093893,2.2817873129082713,0.05783782350427859,0.29050361351012655,0.2490623978653145,MAOA/FMO1/MAOB,3
Metabolism,Amino acid metabolism,hsa00350,Tyrosine metabolism,2/103,36/8538,0.05555555555555555,4.605177993527508,2.395223925304943,0.06965841441825799,0.33677892991829955,0.2887364009778229,MAOA/MAOB,2
Environmental Information Processing,Signal transduction,hsa04010,MAPK signaling pathway,7/103,300/8538,0.023333333333333334,1.9341747572815533,1.8201474476540735,0.07009878179294923,0.33677892991829955,0.2887364009778229,MAPK13/AREG/PLA2G4B/PTPN7/ANGPT2/PGF/CACNA1I,7
Organismal Systems,Immune system,hsa04612,Antigen processing and presentation,3/103,81/8538,0.037037037037037035,3.070118662351672,2.068513188999851,0.07414457088247112,0.34572420620405536,0.29640560665267907,HLA-DRB1/KLRD1/HLA-DRB5,3
Organismal Systems,Nervous system,hsa04728,Dopaminergic synapse,4/103,132/8538,0.030303030303030304,2.5119152691968227,1.9344095850885492,0.07508942035201202,0.34572420620405536,0.29640560665267907,MAOA/MAPK13/MAOB/KCNJ6,4
Human Diseases,Immune disease,hsa05330,Allograft rejection,2/103,39/8538,0.05128205128205128,4.25093353248693,2.2484601177602186,0.080070686394635035,0.3593059656748177,0.308049887218229,HLA-DRB1/HLA-DRB5,2
Human Diseases,Infectious disease: bacterial,hsa05131,Shigellosis,6/103,250/8538,0.024,1.9894368932038835,1.754534622500928,0.081290942460366,0.3593059656748177,0.308049887218229,CXCL8/HKDC1/MAPK13/FOXO6/CYTH4/MAP1LC3C,6
Organismal Systems,Sensory system,hsa04742,Taste transduction,3/103,86/8538,0.03488372093023256,2.891623391284714,1.9481969844181941,0.08526322801915051,0.36947398808298554,0.31676741059746316,HTR3A/HCN4/HTR1D,3
Human Diseases,Cancer: specific types,hsa05219,Bladder cancer,2/103,41/8538,0.04878048780487805,4.043570921146105,2.1585954383377564,0.0872638176290619,0.3707043947427235,0.3178222960404392,MMP1/CXCL8,2
Organismal Systems,Immune system,hsa04610,Complement and coagulation cascades,3/103,88/8538,0.03409090909090909,2.825904677846425,1.90247865318908,0.08989947969734831,0.3707043947427235,0.3178222960404392,SERPINB2/F13A1/C4A,3
Cellular Processes,Cell growth and death,hsa04216,Ferroptosis,2/103,42/8538,0.047619047619047616,3.9472954230235784,2.115776419611899,0.09093081314489661,0.3707043947427235,0.3178222960404392,SLC7A11/MAP1LC3C,2
Environmental Information Processing,Signaling molecules and interaction,hsa04512,ECM-receptor interaction,3/103,89/8538,0.033707865168539325,2.794152939893095,1.8800981364128553,0.09225674982284973,0.3707043947427235,0.3178222960404392,LAMC2/COL4A6/COL4A3,3
Human Diseases,Endocrine and metabolic disease,hsa04940,Type I diabetes mellitus,2/103,44/8538,0.045454545454545456,3.7678729037952343,2.0339724384054287,0.09839756374163207,0.3816894522042345,0.3272403019612394,HLA-DRB1/HLA-DRB5,2
Cellular Processes,Cellular community - eukaryotes,hsa04510,Focal adhesion,5/103,203/8538,0.024630541871921183,2.041704529150127,1.659848609149792,0.09844479084000618,0.3816894522042345,0.3272403019612394,BIRC3/LAMC2/COL4A6/COL4A3/PGF,5
Environmental Information Processing,Signal transduction,hsa04072,Phospholipase D signaling pathway,4/103,149/8538,0.026845637583892617,2.2253209096240307,1.6673109072198067,0.1054113131768764,0.40088961437117826,0.34370150315223663,CXCL8/CYTH4/PLA2G4B/DGKG,4
Human Diseases,Infectious disease: viral,hsa05165,Human papillomavirus infection,7/103,333/8538,0.021021021021021023,1.742499781334733,1.5272420170947678,0.10702482917601593,0.40088961437117826,0.34370150315223663,OASL/LAMC2/COL4A6/ATP6V0D2/PTGS2/COL4A3/WNT6,7
Metabolism,Energy metabolism,hsa00920,Sulfur metabolism,1/103,10/8538,0.1,8.289320388349514,2.548544099903099,0.11435149679178391,0.40374586690088277,0.3461503026537694,SELENBP1,1
Human Diseases,Substance dependence,hsa05030,Cocaine addiction,2/103,49/8538,0.04081632653061224,3.3833960768773523,1.8488203082404255,0.11776690137193621,0.40374586690088277,0.3461503026537694,MAOA/MAOB,2
Cellular Processes,Transport and catabolism,hsa04148,Efferocytosis,4/103,157/8538,0.025477707006369428,2.111928761362934,1.5538445876674603,0.12134845301731795,0.40374586690088277,0.3461503026537694,CD24/SIRPB1/MAPK13/PTGS2,4
Metabolism,Amino acid metabolism,hsa00330,Arginine and proline metabolism,2/103,50/8538,0.04,3.3157281553398055,1.8146739391416582,0.12174939368375262,0.40374586690088277,0.3461503026537694,MAOA/MAOB,2
Metabolism,Carbohydrate metabolism,hsa00520,Amino sugar and nucleotide sugar metabolism,2/103,50/8538,0.04,3.3157281553398055,1.8146739391416582,0.12174939368375262,0.40374586690088277,0.3461503026537694,HKDC1/CYB5R2,2
Human Diseases,Infectious disease: parasitic,hsa05144,Malaria,2/103,50/8538,0.04,3.3157281553398055,1.8146739391416582,0.12174939368375262,0.40374586690088277,0.3461503026537694,CXCL8/IL6,2
Environmental Information Processing,Signaling molecules and interaction,hsa04514,Cell adhesion molecules,4/103,158/8538,0.02531645569620253,2.0985621236327887,1.540138810876978,0.12341059469569848,0.40374586690088277,0.3461503026537694,CD22/LRRC4C/HLA-DRB1/HLA-DRB5,4
Cellular Processes,Transport and catabolism,hsa04145,Phagosome,4/103,159/8538,0.025157232704402517,2.08536361971057,1.5265338428224258,0.12548781545765847,0.40374586690088277,0.3461503026537694,ATP6V0D2/HLA-DRB1/CLEC7A/HLA-DRB5,4
Metabolism,Lipid metabolism,hsa00564,Glycerophospholipid metabolism,3/103,103/8538,0.02912621359223301,2.4143651616551987,1.595755422393064,0.1277938591943773,0.40374586690088277,0.3461503026537694,GPAT3/PLA2G4B/DGKG,3
Human Diseases,Infectious disease: parasitic,hsa05142,Chagas disease,3/103,103/8538,0.02912621359223301,2.4143651616551987,1.595755422393064,0.1277938591943773,0.40374586690088277,0.3461503026537694,CXCL8/IL6/MAPK13,3
Human Diseases,Neurodegenerative disease,hsa05022,Pathways of neurodegeneration - multiple diseases,9/103,483/8538,0.018633540372670808,1.5445938611831396,1.3615771176197997,0.12788330625819816,0.40374586690088277,0.3461503026537694,IL6/MAPK13/DKK1/NOX4/PTGS2/SEPTIN5/MAP1LC3C/DNAH3/WNT6,9
Human Diseases,Infectious disease: viral,hsa05161,Hepatitis B,4/103,163/8538,0.024539877300613498,2.034189052355709,1.4730925736143845,0.1339445189959967,0.41692589715655304,0.35745016188701856,CXCL8/IL6/MAPK13/STAT4,4
Human Diseases,Immune disease,hsa05320,Autoimmune thyroid disease,2/103,54/8538,0.037037037037037035,3.070118662351672,1.6862443215151401,0.13799516787556468,0.4235685013958305,0.363145178619907,HLA-DRB1/HLA-DRB5,2
Environmental Information Processing,Signal transduction,hsa04350,TGF-beta signaling pathway,3/103,108/8538,0.027777777777777776,2.302588996763754,1.5053386253956533,0.14152018199834224,0.42788346894770835,0.3668446030511431,INHBE/GDF6/BMP6,3
Organismal Systems,Immune system,hsa04620,Toll-like receptor signaling pathway,3/103,109/8538,0.027522935779816515,2.281464327068674,1.4878544649642733,0.14432355458227436,0.42788346894770835,0.3668446030511431,CXCL8/IL6/MAPK13,3
Environmental Information Processing,Signal transduction,hsa04151,PI3K-Akt signaling pathway,7/103,362/8538,0.019337016574585635,1.602907257415652,1.2952782264739688,0.14668436558864698,0.42788346894770835,0.3668446030511431,IL6/LAMC2/COL4A6/AREG/COL4A3/ANGPT2/PGF,7
Environmental Information Processing,Signal transduction,hsa04066,HIF-1 signaling pathway,3/103,110/8538,0.02727272727272727,2.2607237422771402,1.470559903867628,0.14714544633495852,0.42788346894770835,0.3668446030511431,IL6/HKDC1/ANGPT2,3
Environmental Information Processing,Signal transduction,hsa04310,Wnt signaling pathway,4/103,174/8538,0.022988505747126436,1.9055908938734516,1.3336085418326604,0.15835209305415818,0.45449107227232416,0.3896565516028499,DKK1/APCDD1/SFRP4/WNT6,4
Organismal Systems,Endocrine system,hsa04928,"Parathyroid hormone synthesis, secretion and action",3/103,115/8538,0.02608695652173913,2.162431405656395,1.3867927556206796,0.16151995304903977,0.4576398669722794,0.39235616125272815,MMP13/MMP24/CYP24A1,3
Human Diseases,Cancer: specific types,hsa05217,Basal cell carcinoma,2/103,63/8538,0.031746031746031744,2.631530282015719,1.4362309119948824,0.176051414151764,0.48915637095085845,0.419376740991448,GLI1/WNT6,2
Human Diseases,Infectious disease: viral,hsa05168,Herpes simplex virus 1 infection,4/103,182/8538,0.02197802197802198,1.8218286567801132,1.23835872615732,0.1770701795297225,0.48915637095085845,0.419376740991448,IL6/BIRC3/HLA-DRB1/HLA-DRB5,4
Organismal Systems,Endocrine system,hsa04929,GnRH secretion,2/103,65/8538,0.03076923076923077,2.5505601194921583,1.3866134050483654,0.18472718125587603,0.4968347997534027,0.4259598187931055,KCNJ6/CACNA1I,2
Human Diseases,Infectious disease: bacterial,hsa05132,Salmonella infection,5/103,251/8538,0.0199203187250996,1.6512590415038872,1.1572326189743662,0.18593077632463076,0.4968347997534027,0.4259598187931055,CXCL8/IL6/BIRC3/MAPK13/CYTH4,5
Metabolism,Metabolism of other amino acids,hsa00430,Taurine and hypotaurine metabolism,1/103,17/8538,0.058823529411764705,4.876070816676185,1.7676634851790307,0.1865940650657576,0.4968347997534027,0.4259598187931055,FMO1,1
Organismal Systems,Immune system,hsa04611,Platelet activation,3/103,126/8538,0.023809523809523808,1.9736477115117892,1.216651504672033,0.19451870508702135,0.5117694502884729,0.4387639964368903,COL3A1/MAPK13/PLA2G4B,3
Organismal Systems,Immune system,hsa04664,Fc epsilon RI signaling pathway,2/103,69/8538,0.028985507246376812,2.402701561840439,1.2927140502462613,0.2022544573038909,0.5146509599139089,0.44123445003335837,MAPK13/PLA2G4B,2
Human Diseases,Substance dependence,hsa05031,Amphetamine addiction,2/103,69/8538,0.028985507246376812,2.402701561840439,1.2927140502462613,0.2022544573038909,0.5146509599139089,0.44123445003335837,MAOA/MAOB,2
Human Diseases,Cardiovascular disease,hsa05416,Viral myocarditis,2/103,70/8538,0.02857142857142857,2.3683772538141468,1.2702615466887757,0.20666727664639103,0.5146509599139089,0.44123445003335837,HLA-DRB1/HLA-DRB5,2
Human Diseases,Cancer: overview,hsa05204,Chemical carcinogenesis - DNA adducts,2/103,71/8538,0.028169014084507043,2.3350198277040883,1.2481903480392018,0.2110906542738595,0.5146509599139089,0.44123445003335837,HSD11B1/PTGS2,2
Organismal Systems,Immune system,hsa04622,RIG-I-like receptor signaling pathway,2/103,72/8538,0.027777777777777776,2.302588996763754,1.2264877955786786,0.215523704238309,0.5146509599139089,0.44123445003335837,CXCL8/MAPK13,2
Metabolism,Lipid metabolism,hsa00100,Steroid biosynthesis,1/103,20/8538,0.05,4.144660194174757,1.555781535598959,0.21573915323508508,0.5146509599139089,0.44123445003335837,CYP24A1,1
Metabolism,Metabolism of cofactors and vitamins,hsa00785,Lipoic acid metabolism,1/103,20/8538,0.05,4.144660194174757,1.555781535598959,0.21573915323508508,0.5146509599139089,0.44123445003335837,GLDC,1
Environmental Information Processing,Signal transduction,hsa04068,FoxO signaling pathway,3/103,133/8538,0.022556390977443608,1.8697715161690633,1.1170969143576157,0.21633086470148313,0.5146509599139089,0.44123445003335837,IL6/MAPK13/FOXO6,3
Human Diseases,Cancer: overview,hsa05202,Transcriptional misregulation in cancer,4/103,198/8538,0.020202020202020204,1.6746101794645485,1.061282907027653,0.21657257589137338,0.5146509599139089,0.44123445003335837,CXCL8/IL6/BIRC3/MMP3,4
Human Diseases,Infectious disease: bacterial,hsa05130,Pathogenic Escherichia coli infection,4/103,203/8538,0.019704433497536946,1.6333636233201014,1.0091995377150127,0.22939461508092465,0.5345875038627057,0.4583269859265874,CXCL8/IL6/MAPK13/CYTH4,4
Human Diseases,Infectious disease: viral,hsa05169,Epstein-Barr virus infection,4/103,204/8538,0.0196078431372549,1.6253569388920617,0.9989529146024809,0.23198250410899451,0.5345875038627057,0.4583269859265874,IL6/MAPK13/HLA-DRB1/HLA-DRB5,4
Human Diseases,Infectious disease: bacterial,hsa05135,Yersinia infection,3/103,138/8538,0.021739130434782608,1.8020261713803292,1.0495838752039701,0.23221900620280428,0.5345875038627057,0.4583269859265874,CXCL8/IL6/MAPK13,3
Organismal Systems,Endocrine system,hsa04915,Estrogen signaling pathway,3/103,139/8538,0.02158273381294964,1.789061954320039,1.0364143628346487,0.23542311653120324,0.5363763789009888,0.4598606725514551,KRT17/KRT15/KCNJ6,3
Human Diseases,Immune disease,hsa05322,Systemic lupus erythematosus,3/103,141/8538,0.02127659574468085,1.7636851890105352,1.0103935316117054,0.2418552262493335,0.5454082142969664,0.4676040894186899,C4A/HLA-DRB1/HLA-DRB5,3
Cellular Processes,Cellular community - eukaryotes,hsa04550,Signaling pathways regulating pluripotency of stem cells,3/103,144/8538,0.020833333333333332,1.7269417475728155,0.972131652414294,0.25155834877387767,0.5591219222638855,0.47936149562990893,MAPK13/INHBE/WNT6,3
Metabolism,Glycan biosynthesis and metabolism,hsa00534,Glycosaminoglycan biosynthesis - heparan sulfate / heparin,1/103,24/8538,0.041666666666666664,3.453883495145631,1.3302137941292917,0.25299634491578527,0.5591219222638855,0.47936149562990893,HS6ST3,1
Organismal Systems,Immune system,hsa04623,Cytosolic DNA-sensing pathway,2/103,83/8538,0.024096385542168676,1.9974265996022929,1.009001694825019,0.2646910578531848,0.5791754830252857,0.4965543555348959,IL6/AIM2,2
Organismal Systems,Nervous system,hsa04723,Retrograde endocannabinoid signaling,3/103,149/8538,0.020134228187919462,1.668990682218023,0.910304763862045,0.26785605057632705,0.5803547762487086,0.49756541902723295,MAPK13/PTGS2/KCNJ6,3
Metabolism,Lipid metabolism,hsa00592,alpha-Linolenic acid metabolism,1/103,26/8538,0.038461538461538464,3.188200149365198,1.2347715641479078,0.2709621502216151,0.5813848077570576,0.49844851343782026,PLA2G4B,1
Metabolism,Global and overview maps,hsa01240,Biosynthesis of cofactors,3/103,153/8538,0.0196078431372549,1.6253569388920617,0.8624836374424862,0.2809857240478631,0.5910274264109803,0.5067155834911952,KYNU/CMPK2/NMNAT2,3
Organismal Systems,Endocrine system,hsa04921,Oxytocin signaling pathway,3/103,155/8538,0.01935483870967742,1.6043845912934545,0.8390893504186843,0.2875746270564029,0.5910274264109803,0.5067155834911952,PTGS2/PLA2G4B/KCNJ6,3
Metabolism,Glycan biosynthesis and metabolism,hsa00601,Glycosphingolipid biosynthesis - lacto and neolacto series,1/103,28/8538,0.03571428571428571,2.9604715672676836,1.1481628569406206,0.28849996400008815,0.5910274264109803,0.5067155834911952,B3GALT2,1
Organismal Systems,Excretory system,hsa04966,Collecting duct acid secretion,1/103,28/8538,0.03571428571428571,2.9604715672676836,1.1481628569406206,0.28849996400008815,0.5910274264109803,0.5067155834911952,ATP6V0D2,1
Human Diseases,Infectious disease: viral,hsa05163,Human cytomegalovirus infection,4/103,226/8538,0.017699115044247787,1.467136351920268,0.7864549073657737,0.2904935096011529,0.5910274264109803,0.5067155834911952,CXCL8/IL6/MAPK13/PTGS2,4
Cellular Processes,Cell growth and death,hsa04218,Cellular senescence,3/103,157/8538,0.01910828025477707,1.5839465710222,0.8160254958758595,0.29417654708238833,0.5910274264109803,0.5067155834911952,CXCL8/IL6/MAPK13,3
Human Diseases,Endocrine and metabolic disease,hsa04932,Non-alcoholic fatty liver disease,3/103,157/8538,0.01910828025477707,1.5839465710222,0.8160254958758595,0.29417654708238833,0.5910274264109803,0.5067155834911952,CXCL8/IL6/MAPK13,3
Cellular Processes,Cell growth and death,hsa04217,Necroptosis,3/103,159/8538,0.018867924528301886,1.5640227147829273,0.7932823125823205,0.300789269145827,0.5977167652786761,0.5124506680169645,BIRC3/PLA2G4B/STAT4,3
Metabolism,Lipid metabolism,hsa00591,Linoleic acid metabolism,1/103,30/8538,0.03333333333333333,2.7631067961165052,1.0689421833041557,0.30561988450900635,0.5977167652786761,0.5124506680169645,PLA2G4B,1
Human Diseases,Drug resistance: antineoplastic,hsa01523,Antifolate resistance,1/103,30/8538,0.03333333333333333,2.7631067961165052,1.0689421833041557,0.30561988450900635,0.5977167652786761,0.5124506680169645,IL6,1
Organismal Systems,Endocrine system,hsa04912,GnRH signaling pathway,2/103,93/8538,0.021505376344086023,1.782649545881616,0.8385668587227113,0.30947616936554134,0.5982741026446733,0.5129284995286554,MAPK13/PLA2G4B,2
Metabolism,Carbohydrate metabolism,hsa00630,Glyoxylate and dicarboxylate metabolism,1/103,31/8538,0.03225806451612903,2.6739743188224243,1.0317396742753608,0.31402622582254347,0.5982741026446733,0.5129284995286554,GLDC,1
NA,NA,hsa04981,Folate transport and metabolism,1/103,31/8538,0.03225806451612903,2.6739743188224243,1.0317396742753608,0.31402622582254347,0.5982741026446733,0.5129284995286554,SLCO2B1,1
Metabolism,Carbohydrate metabolism,hsa00052,Galactose metabolism,1/103,32/8538,0.03125,2.5904126213592233,0.99598047149449,0.3223317740463916,0.6036891700360384,0.5175710912430909,HKDC1,1
Cellular Processes,Cell growth and death,hsa04215,Apoptosis - multiple species,1/103,32/8538,0.03125,2.5904126213592233,0.99598047149449,0.3223317740463916,0.6036891700360384,0.5175710912430909,BIRC3,1
Organismal Systems,Environmental adaptation,hsa04713,Circadian entrainment,2/103,97/8538,0.020618556701030927,1.7091382244019617,0.7761551119667609,0.3272692980882348,0.6077858393067218,0.521083358300595,KCNJ6/CACNA1I,2
Environmental Information Processing,Signal transduction,hsa04630,JAK-STAT signaling pathway,3/103,168/8538,0.017857142857142856,1.4802357836338418,0.6946645535518117,0.33062307178444916,0.6084601905255635,0.5216615112865036,IL24/IL6/STAT4,3
Organismal Systems,Sensory system,hsa04750,Inflammatory mediator regulation of TRP channels,2/103,99/8538,0.020202020202020204,1.6746101794645485,0.7460255535922244,0.336123249132514,0.6084601905255635,0.5216615112865036,MAPK13/PLA2G4B,2
Human Diseases,Cancer: overview,hsa05231,Choline metabolism in cancer,2/103,99/8538,0.020202020202020204,1.6746101794645485,0.7460255535922244,0.336123249132514,0.6084601905255635,0.5216615112865036,PLA2G4B/DGKG,2
Metabolism,Carbohydrate metabolism,hsa00051,Fructose and mannose metabolism,1/103,34/8538,0.029411764705882353,2.4380354083380924,0.9283807399173603,0.3386452644101553,0.6084601905255635,0.5216615112865036,HKDC1,1
Metabolism,Glycan biosynthesis and metabolism,hsa00512,Mucin type O-glycan biosynthesis,1/103,36/8538,0.027777777777777776,2.302588996763754,0.8654197755253498,0.35456976223268644,0.6319348181727718,0.5417874125796568,GALNT9,1
Metabolism,Global and overview maps,hsa01250,Biosynthesis of nucleotide sugars,1/103,37/8538,0.02702702702702703,2.240356861716085,0.8354899247741311,0.36238901823010283,0.6356188335623232,0.5449458920753426,HKDC1,1
Human Diseases,Infectious disease: parasitic,hsa05143,African trypanosomiasis,1/103,37/8538,0.02702702702702703,2.240356861716085,0.8354899247741311,0.36238901823010283,0.6356188335623232,0.5449458920753426,IL6,1
Metabolism,Metabolism of cofactors and vitamins,hsa00760,Nicotinate and nicotinamide metabolism,1/103,38/8538,0.02631578947368421,2.1814001021972405,0.8065068291216914,0.3701144541932011,0.6440574360369877,0.5521807024846763,NMNAT2,1
Metabolism,Metabolism of cofactors and vitamins,hsa00670,One carbon pool by folate,1/103,39/8538,0.02564102564102564,2.125466766243465,0.7784124506006544,0.37774718492474224,0.6522041239716253,0.5591652408425462,GLDC,1
Metabolism,Carbohydrate metabolism,hsa00500,Starch and sucrose metabolism,1/103,40/8538,0.025,2.0723300970873786,0.7511537459641351,0.3852883121106172,0.6600675734608248,0.56590694557251,HKDC1,1
Metabolism,Global and overview maps,hsa01200,Carbon metabolism,2/103,116/8538,0.017241379310344827,1.4291931704050886,0.5142838521530531,0.40971288505821934,0.6965119045989728,0.5971523830808055,HKDC1/GLDC,2
Organismal Systems,Immune system,hsa04062,Chemokine signaling pathway,3/103,193/8538,0.015544041450777202,1.2884953971527742,0.4479536525552525,0.4129325423382064,0.6966266553949895,0.5972507643300695,CXCL8/CXCL1/CCL20,3
Environmental Information Processing,Membrane transport,hsa02010,ABC transporters,1/103,45/8538,0.022222222222222223,1.8420711974110033,0.6258254455785399,0.42165755478690103,0.7059569667265541,0.6052500786414848,ABCA13,1
Organismal Systems,Nervous system,hsa04722,Neurotrophin signaling pathway,2/103,120/8538,0.016666666666666666,1.3815533980582526,0.4651255510881625,0.42648141765598047,0.7086646112930202,0.6075714695534348,IRAK2/MAPK13,2
Metabolism,Glycan biosynthesis and metabolism,hsa00514,Other types of O-glycan biosynthesis,1/103,47/8538,0.02127659574468085,1.7636851890105352,0.5801129842291158,0.43560115999536086,0.7130952322887019,0.611370049116296,GALNT9,1
Human Diseases,Endocrine and metabolic disease,hsa04930,Type II diabetes mellitus,1/103,47/8538,0.02127659574468085,1.7636851890105352,0.5801129842291158,0.43560115999536086,0.7130952322887019,0.611370049116296,HKDC1,1
Metabolism,Lipid metabolism,hsa00565,Ether lipid metabolism,1/103,50/8538,0.02,1.6578640776699027,0.5155219944501038,0.45589468199113137,0.7408288582355884,0.6351473897709261,PLA2G4B,1
Human Diseases,Infectious disease: bacterial,hsa05110,Vibrio cholerae infection,1/103,51/8538,0.0196078431372549,1.6253569388920617,0.49495380770871594,0.46249727951173847,0.7460722538109066,0.6396427991710559,ATP6V0D2,1
Organismal Systems,Digestive system,hsa04973,Carbohydrate digestion and absorption,1/103,52/8538,0.019230769230769232,1.594100074682599,0.4748303548738907,0.4690205244994007,0.7511125790896199,0.6439641068641657,HKDC1,1
Environmental Information Processing,Signal transduction,hsa04015,Rap1 signaling pathway,3/103,212/8538,0.014150943396226415,1.1730170360871954,0.28188197437099455,0.4734567861391201,0.7527622283219104,0.6453784286637003,MAPK13/ANGPT2/PGF,3
Organismal Systems,Circulatory system,hsa04270,Vascular smooth muscle contraction,2/103,134/8538,0.014925373134328358,1.2372119982611216,0.305826235511836,0.48314106825405734,0.7626726863153334,0.6538751299678971,PLA2G4B/ADM2,2
Environmental Information Processing,Signal transduction,hsa04340,Hedgehog signaling pathway,1/103,56/8538,0.017857142857142856,1.4802357836338418,0.39840805133441926,0.4943387019434369,0.768992226222292,0.6592931684687429,GLI1,1
Metabolism,Nucleotide metabolism,hsa00240,Pyrimidine metabolism,1/103,58/8538,0.017241379310344827,1.4291931704050886,0.3624078388286647,0.5065457085282639,0.768992226222292,0.6592931684687429,CMPK2,1
Human Diseases,Infectious disease: viral,hsa05166,Human T-cell leukemia virus 1 infection,3/103,224/8538,0.013392857142857142,1.1101768377253813,0.184645195561729,0.5102368872020557,0.768992226222292,0.6592931684687429,IL6/HLA-DRB1/HLA-DRB5,3
Human Diseases,Neurodegenerative disease,hsa05010,Alzheimer disease,5/103,391/8538,0.01278772378516624,1.0600153949296054,0.13423967698123002,0.5123864275713885,0.768992226222292,0.6592931684687429,IL6/DKK1/NOX4/PTGS2/WNT6,5
Metabolism,Metabolism of other amino acids,hsa00480,Glutathione metabolism,1/103,59/8538,0.01694915254237288,1.4049695573473753,0.34490919713146484,0.5125393160779794,0.768992226222292,0.6592931684687429,CHAC1,1
Organismal Systems,Endocrine system,hsa04923,Regulation of lipolysis in adipocytes,1/103,59/8538,0.01694915254237288,1.4049695573473753,0.34490919713146484,0.5125393160779794,0.768992226222292,0.6592931684687429,PTGS2,1
Environmental Information Processing,Signal transduction,hsa04024,cAMP signaling pathway,3/103,226/8538,0.01327433628318584,1.100352263940201,0.16894966558823327,0.5162396735833914,0.768992226222292,0.6592931684687429,GLI1/HCN4/HTR1D,3
Organismal Systems,Development and regeneration,hsa04380,Osteoclast differentiation,2/103,143/8538,0.013986013986013986,1.159345508860072,0.21233725833930828,0.517728610240648,0.768992226222292,0.6592931684687429,SIRPB1/MAPK13,2
Organismal Systems,Nervous system,hsa04730,Long-term depression,1/103,60/8538,0.016666666666666666,1.3815533980582526,0.3277275522760466,0.5184608222041698,0.768992226222292,0.6592931684687429,PLA2G4B,1
Metabolism,Lipid metabolism,hsa00140,Steroid hormone biosynthesis,1/103,63/8538,0.015873015873015872,1.3157651410078595,0.2779670481418262,0.5358012710733899,0.7894138727147946,0.6768016055663872,HSD11B1,1
Organismal Systems,Endocrine system,hsa04927,Cortisol synthesis and secretion,1/103,65/8538,0.015384615384615385,1.2752800597460792,0.24617363505482487,0.5470165428310725,0.8006003706335564,0.6863923158563475,CACNA1I,1
Environmental Information Processing,Signal transduction,hsa04014,Ras signaling pathway,3/103,238/8538,0.012605042016806723,1.0448723178591826,0.07758122724221839,0.5514246001656702,0.8017423462935073,0.6873713852480653,PLA2G4B/ANGPT2/PGF,3
Metabolism,Carbohydrate metabolism,hsa00010,Glycolysis / Gluconeogenesis,1/103,67/8538,0.014925373134328358,1.2372119982611216,0.21539490296826033,0.5579634157441767,0.8032112350762922,0.6886307326207792,HKDC1,1
Human Diseases,Endocrine and metabolic disease,hsa04934,Cushing syndrome,2/103,155/8538,0.012903225806451613,1.0695897275289696,0.09661397743964738,0.5614308336577634,0.8032112350762922,0.6886307326207792,WNT6/CACNA1I,2
Metabolism,Metabolism of cofactors and vitamins,hsa00830,Retinol metabolism,1/103,68/8538,0.014705882352941176,1.2190177041690462,0.20036445663883548,0.5633381965467208,0.8032112350762922,0.6886307326207792,DHRS9,1
Organismal Systems,Endocrine system,hsa04917,Prolactin signaling pathway,1/103,71/8538,0.014084507042253521,1.1675099138520442,0.15661509539567983,0.5790772625973233,0.815134235885404,0.6988528814449761,MAPK13,1
Human Diseases,Cancer: overview,hsa05230,Central carbon metabolism in cancer,1/103,71/8538,0.014084507042253521,1.1675099138520442,0.15661509539567983,0.5790772625973233,0.815134235885404,0.6988528814449761,HKDC1,1
Human Diseases,Drug resistance: antineoplastic,hsa01524,Platinum drug resistance,1/103,75/8538,0.013333333333333334,1.105242718446602,0.10115543647441484,0.599191934192032,0.83811023706607,0.7185512868392122,BIRC3,1
Organismal Systems,Endocrine system,hsa03320,PPAR signaling pathway,1/103,76/8538,0.013157894736842105,1.0907000510986202,0.08776200307181233,0.6040700188875561,0.8396193344286156,0.7198451069166507,MMP1,1
Metabolism,Xenobiotics biodegradation and metabolism,hsa00980,Metabolism of xenobiotics by cytochrome P450,1/103,79/8538,0.012658227848101266,1.0492810618163944,0.04862535661048737,0.6183542729648304,0.8487968591629038,0.7277134300991792,HSD11B1,1
Organismal Systems,Nervous system,hsa04721,Synaptic vesicle cycle,1/103,79/8538,0.012658227848101266,1.0492810618163944,0.04862535661048737,0.6183542729648304,0.8487968591629038,0.7277134300991792,ATP6V0D2,1
Human Diseases,Drug resistance: antineoplastic,hsa01521,EGFR tyrosine kinase inhibitor resistance,1/103,80/8538,0.0125,1.0361650485436893,0.03591111709835436,0.6230013364338718,0.8498968848881832,0.7286565338407858,IL6,1
Human Diseases,Neurodegenerative disease,hsa05012,Parkinson disease,3/103,271/8538,0.01107011070110701,0.9176369433597247,-0.15225509756597522,0.6400755816322887,0.8606984220482228,0.7379171991839967,MAOA/MAOB/SEPTIN5,3
Metabolism,Global and overview maps,hsa01232,Nucleotide metabolism,1/103,85/8538,0.011764705882352941,0.975214163335237,-0.025376768708053818,0.6454092963631448,0.8606984220482228,0.7379171991839967,CMPK2,1
Environmental Information Processing,Signal transduction,hsa04012,ErbB signaling pathway,1/103,86/8538,0.011627906976744186,0.9638744637615714,-0.0372059581650646,0.6497299922669181,0.8606984220482228,0.7379171991839967,AREG,1
Human Diseases,Cancer: specific types,hsa05210,Colorectal cancer,1/103,87/8538,0.011494252873563218,0.9527954469367258,-0.04890104895773504,0.6539985453663628,0.8606984220482228,0.7379171991839967,AREG,1
Environmental Information Processing,Signaling molecules and interaction,hsa04080,Neuroactive ligand-receptor interaction,4/103,370/8538,0.010810810810810811,0.896142744686434,-0.2256880417106576,0.6585637039972122,0.8606984220482228,0.7379171991839967,SPX/PRSS3/ADM2/HTR1D,4
Organismal Systems,Nervous system,hsa04727,GABAergic synapse,1/103,89/8538,0.011235955056179775,0.9313843132976983,-0.07190257966824863,0.6623817084638765,0.8606984220482228,0.7379171991839967,KCNJ6,1
Human Diseases,Cancer: overview,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,1/103,90/8538,0.011111111111111112,0.9210355987055017,-0.08321552522701918,0.6664975427671338,0.8606984220482228,0.7379171991839967,MAPK13,1
Human Diseases,Substance dependence,hsa05034,Alcoholism,2/103,188/8538,0.010638297872340425,0.8818425945052676,-0.1810194923564921,0.6667980279432175,0.8606984220482228,0.7379171991839967,MAOA/MAOB,2
Organismal Systems,Immune system,hsa04662,B cell receptor signaling pathway,1/103,91/8538,0.01098901098901099,0.9109143283900566,-0.0944073956290771,0.6705636830482635,0.8606984220482228,0.7379171991839967,CD22,1
Human Diseases,Substance dependence,hsa05032,Morphine addiction,1/103,91/8538,0.01098901098901099,0.9109143283900566,-0.0944073956290771,0.6705636830482635,0.8606984220482228,0.7379171991839967,KCNJ6,1
Organismal Systems,Immune system,hsa04613,Neutrophil extracellular trap formation,2/103,193/8538,0.010362694300518135,0.8589969314351829,-0.21893881222534817,0.6808753497156519,0.8606984220482228,0.7379171991839967,MAPK13/CLEC7A,2
Cellular Processes,Cell motility,hsa04814,Motor proteins,2/103,197/8538,0.01015228426395939,0.8415553693755852,-0.24861669479330015,0.6917891735706578,0.8606984220482228,0.7379171991839967,KIF26B/DNAH3,2
Environmental Information Processing,Signal transduction,hsa04070,Phosphatidylinositol signaling system,1/103,98/8538,0.01020408163265306,0.8458490192193381,-0.1695964730575764,0.6976842679766062,0.8606984220482228,0.7379171991839967,DGKG,1
Organismal Systems,Endocrine system,hsa04925,Aldosterone synthesis and secretion,1/103,98/8538,0.01020408163265306,0.8458490192193381,-0.1695964730575764,0.6976842679766062,0.8606984220482228,0.7379171991839967,CACNA1I,1
Human Diseases,Cancer: specific types,hsa05215,Prostate cancer,1/103,98/8538,0.01020408163265306,0.8458490192193381,-0.1695964730575764,0.6976842679766062,0.8606984220482228,0.7379171991839967,MMP3,1
Human Diseases,Drug resistance: antineoplastic,hsa01522,Endocrine resistance,1/103,99/8538,0.010101010101010102,0.8373050897322742,-0.1799180685287832,0.7013736661280765,0.8606984220482228,0.7379171991839967,MAPK13,1
Organismal Systems,Immune system,hsa04666,Fc gamma R-mediated phagocytosis,1/103,99/8538,0.010101010101010102,0.8373050897322742,-0.1799180685287832,0.7013736661280765,0.8606984220482228,0.7379171991839967,PLA2G4B,1
Human Diseases,Cardiovascular disease,hsa05410,Hypertrophic cardiomyopathy,1/103,99/8538,0.010101010101010102,0.8373050897322742,-0.1799180685287832,0.7013736661280765,0.8606984220482228,0.7379171991839967,IL6,1
Organismal Systems,Endocrine system,hsa04916,Melanogenesis,1/103,101/8538,0.009900990099009901,0.8207247909256945,-0.20026986708877145,0.7086192178015442,0.8606984220482228,0.7379171991839967,WNT6,1
Human Diseases,Cancer: overview,hsa05205,Proteoglycans in cancer,2/103,204/8538,0.00980392156862745,0.8126784694460308,-0.2992297314973642,0.7101561956070936,0.8606984220482228,0.7379171991839967,MAPK13/WNT6,2
Human Diseases,Cardiovascular disease,hsa05415,Diabetic cardiomyopathy,2/103,205/8538,0.00975609756097561,0.8087141842292209,-0.30632872029377756,0.7127050282118768,0.8606984220482228,0.7379171991839967,COL3A1/MAPK13,2
Cellular Processes,Transport and catabolism,hsa04137,Mitophagy - animal,1/103,105/8538,0.009523809523809525,0.7894590846047157,-0.23986606788149625,0.72259206805726,0.8672521502390234,0.7435360183044736,MAP1LC3C,1
Organismal Systems,Digestive system,hsa04972,Pancreatic secretion,1/103,106/8538,0.009433962264150943,0.7820113573914637,-0.2495457687124226,0.7259803067611734,0.8672521502390234,0.7435360183044736,PRSS3,1
Human Diseases,Endocrine and metabolic disease,hsa04931,Insulin resistance,1/103,109/8538,0.009174311926605505,0.7604881090228913,-0.2780872076380713,0.7359010605170695,0.874377066528346,0.7496445438204443,IL6,1
Organismal Systems,Endocrine system,hsa04914,Progesterone-mediated oocyte maturation,1/103,111/8538,0.009009009009009009,0.7467856205720284,-0.29671675216986754,0.7423164320439579,0.8772830560519503,0.7521359851838583,MAPK13,1
Organismal Systems,Immune system,hsa04670,Leukocyte transendothelial migration,1/103,116/8538,0.008620689655172414,0.7145965852025443,-0.34198672695825105,0.7576875470536998,0.8813102520993035,0.7555886895826369,MAPK13,1
Organismal Systems,Nervous system,hsa04724,Glutamatergic synapse,1/103,116/8538,0.008620689655172414,0.7145965852025443,-0.34198672695825105,0.7576875470536998,0.8813102520993035,0.7555886895826369,PLA2G4B,1
Organismal Systems,Nervous system,hsa04725,Cholinergic synapse,1/103,116/8538,0.008620689655172414,0.7145965852025443,-0.34198672695825105,0.7576875470536998,0.8813102520993035,0.7555886895826369,KCNJ6,1
Human Diseases,Cancer: overview,hsa05208,Chemical carcinogenesis - reactive oxygen species,2/103,227/8538,0.00881057268722467,0.7303365980924683,-0.4550268311461277,0.7642204550987455,0.8827906077717514,0.7568578680586581,MAPK13/NOX4,2
Environmental Information Processing,Signal transduction,hsa04071,Sphingolipid signaling pathway,1/103,122/8538,0.00819672131147541,0.6794524908483209,-0.39404712938215763,0.7749383615733927,0.8827906077717514,0.7568578680586581,MAPK13,1
Organismal Systems,Immune system,hsa04660,T cell receptor signaling pathway,1/103,122/8538,0.00819672131147541,0.6794524908483209,-0.39404712938215763,0.7749383615733927,0.8827906077717514,0.7568578680586581,MAPK13,1
Organismal Systems,Endocrine system,hsa04935,"Growth hormone synthesis, secretion and action",1/103,122/8538,0.00819672131147541,0.6794524908483209,-0.39404712938215763,0.7749383615733927,0.8827906077717514,0.7568578680586581,MAPK13,1
Cellular Processes,Transport and catabolism,hsa04142,Lysosome,1/103,133/8538,0.007518796992481203,0.6232571720563544,-0.4838721926143226,0.8034654668238941,0.8921217542487474,0.764857898379493,ATP6V0D2,1
Organismal Systems,Immune system,hsa04650,Natural killer cell mediated cytotoxicity,1/103,134/8538,0.007462686567164179,0.6186059991305608,-0.4917132876402888,0.8058739209484792,0.8921217542487474,0.764857898379493,KLRD1,1
Cellular Processes,Cell growth and death,hsa04210,Apoptosis,1/103,136/8538,0.007352941176470588,0.6095088520845231,-0.5072452845548272,0.8106034857636037,0.8921217542487474,0.764857898379493,BIRC3,1
Metabolism,Energy metabolism,hsa00190,Oxidative phosphorylation,1/103,138/8538,0.007246376811594203,0.6006753904601098,-0.5225822873383977,0.8152189141382087,0.8921217542487474,0.764857898379493,ATP6V0D2,1
Organismal Systems,Endocrine system,hsa04910,Insulin signaling pathway,1/103,138/8538,0.007246376811594203,0.6006753904601098,-0.5225822873383977,0.8152189141382087,0.8921217542487474,0.764857898379493,HKDC1,1
Cellular Processes,Cell growth and death,hsa04114,Oocyte meiosis,1/103,139/8538,0.007194244604316547,0.5963539847733464,-0.5301795700470422,0.8174846822148473,0.8921217542487474,0.764857898379493,MAPK13,1
Human Diseases,Infectious disease: viral,hsa05162,Measles,1/103,139/8538,0.007194244604316547,0.5963539847733464,-0.5301795700470422,0.8174846822148473,0.8921217542487474,0.764857898379493,IL6,1
Environmental Information Processing,Signal transduction,hsa04371,Apelin signaling pathway,1/103,140/8538,0.007142857142857143,0.5920943134535367,-0.5377303536206005,0.8197229341176775,0.8921217542487474,0.764857898379493,MAP1LC3C,1
Human Diseases,Cardiovascular disease,hsa05418,Fluid shear stress and atherosclerosis,1/103,141/8538,0.0070921985815602835,0.5878950630035117,-0.5452353517893841,0.8219340007747242,0.8921217542487474,0.764857898379493,MAPK13,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04120,Ubiquitin mediated proteolysis,1/103,142/8538,0.007042253521126761,0.5837549569260221,-0.5526952618966743,0.824118209172986,0.8921217542487474,0.764857898379493,BIRC3,1
Human Diseases,Neurodegenerative disease,hsa05017,Spinocerebellar ataxia,1/103,144/8538,0.006944444444444444,0.5756472491909385,-0.5674825283153002,0.8284073397142898,0.8921217542487474,0.764857898379493,BEAN1,1
Human Diseases,Neurodegenerative disease,hsa05014,Amyotrophic lateral sclerosis,3/103,371/8538,0.008086253369272238,0.6702954491926832,-0.7174792214839677,0.8315705039603709,0.8921217542487474,0.764857898379493,MAPK13/MAP1LC3C/DNAH3,3
Human Diseases,Cancer: specific types,hsa05224,Breast cancer,1/103,148/8538,0.006756756756756757,0.5600892154290212,-0.5965449806339773,0.8366772624278412,0.8932043878298476,0.7657860910186832,WNT6,1
Human Diseases,Cancer: specific types,hsa05226,Gastric cancer,1/103,150/8538,0.006666666666666667,0.552621359223301,-0.6108300215350625,0.8406629532516212,0.8932043878298476,0.7657860910186832,WNT6,1
Organismal Systems,Circulatory system,hsa04261,Adrenergic signaling in cardiomyocytes,1/103,154/8538,0.006493506493506494,0.5382675576850334,-0.6389308018439684,0.8483476082399855,0.8962179129830276,0.7683697277301498,MAPK13,1
Human Diseases,Neurodegenerative disease,hsa05020,Prion disease,2/103,278/8538,0.007194244604316547,0.5963539847733464,-0.756069560097156,0.8539961533322271,0.8962179129830276,0.7683697277301498,IL6/MAPK13,2
Environmental Information Processing,Signal transduction,hsa04150,mTOR signaling pathway,1/103,158/8538,0.006329113924050633,0.5246405309081972,-0.6664343797373478,0.855665066241714,0.8962179129830276,0.7683697277301498,WNT6,1
Cellular Processes,Transport and catabolism,hsa04140,Autophagy - animal,1/103,169/8538,0.005917159763313609,0.49049233067156894,-0.7392409280153935,0.8740337330330805,0.9084698263446922,0.7788738687403886,MAP1LC3C,1
Human Diseases,Cancer: specific types,hsa05225,Hepatocellular carcinoma,1/103,170/8538,0.0058823529411764705,0.4876070816676185,-0.7456679097112118,0.8755840407756534,0.9084698263446922,0.7788738687403886,WNT6,1
Human Diseases,Cancer: overview,hsa05206,MicroRNAs in cancer,2/103,312/8538,0.00641025641025641,0.5313666915608662,-0.9318474200927215,0.8953741266536501,0.9203923393425156,0.7890955993410471,PTGS2/CYP24A1,2
Organismal Systems,Development and regeneration,hsa04360,Axon guidance,1/103,184/8538,0.005434782608695652,0.4505065428450823,-0.8326316423248092,0.8954043120300492,0.9203923393425156,0.7890955993410471,LRRC4C,1
Human Diseases,Cancer: overview,hsa05203,Viral carcinogenesis,1/103,205/8538,0.004878048780487805,0.40435709211461046,-0.9538738091445508,0.9194191742388046,0.9407020254943325,0.8065080475778987,ATP6V0D2,1
Human Diseases,Infectious disease: viral,hsa05170,Human immunodeficiency virus 1 infection,1/103,213/8538,0.004694835680751174,0.38916997128401476,-0.9975777849501376,0.927054069865485,0.9441426241487196,0.8094578344690143,MAPK13,1
Organismal Systems,Environmental adaptation,hsa04714,Thermogenesis,1/103,235/8538,0.00425531914893617,0.352737037802107,-1.1117979738057844,0.9445500821969275,0.9575484778234907,0.8209513027303088,MAPK13,1
Cellular Processes,Transport and catabolism,hsa04144,Endocytosis,1/103,252/8538,0.003968253968253968,0.32894128525196487,-1.1948600374827625,0.9551614789182012,0.9606160357689937,0.823581264293493,CYTH4,1
Environmental Information Processing,Signal transduction,hsa04020,Calcium signaling pathway,1/103,254/8538,0.003937007874015748,0.32635119639171317,-1.2043676056768526,0.9562693568741113,0.9606160357689937,0.823581264293493,CACNA1I,1
Human Diseases,Neurodegenerative disease,hsa05016,Huntington disease,1/103,311/8538,0.003215434083601286,0.2665376330659008,-1.4560154758897073,0.9786200432185688,0.9786200432185688,0.8390169458411163,DNAH3,1
